{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:58:10Z","timestamp":1781848690457,"version":"3.54.5"},"reference-count":169,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.rdc.2023.01.002","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T22:08:41Z","timestamp":1680732521000},"page":"211-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6849-9114","authenticated-orcid":false,"given":"Cec\u00edlia","family":"Varj\u00fa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2793-2364","authenticated-orcid":false,"given":"John D.","family":"Pauling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1878-8591","authenticated-orcid":false,"given":"Lesley Ann","family":"Saketkoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib1","doi-asserted-by":"crossref","first-page":"101707","DOI":"10.1016\/j.berh.2021.101707","article-title":"A\u00a0comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc","volume":"35","author":"Saketkoo","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/rheumatology\/kex420","article-title":"Wildflowers abundant in the garden of systemic sclerosis research, while hopeful exotics will one day bloom","volume":"57","author":"Saketkoo","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2023.01.002_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.bor.0000434666.47397.c2","article-title":"Psychosocial aspects of systemic sclerosis","volume":"25","author":"Malcarne","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"2 Suppl 76","key":"10.1016\/j.rdc.2023.01.002_bib4","first-page":"37","article-title":"Psychological characteristics of systemic sclerosis patients and their correlation with major organ involvement and disease activity","volume":"31","author":"Golemati","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.002_bib5","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1093\/rheumatology\/keab083","article-title":"Happiness, quality of life and their determinants among people with systemic sclerosis: a structural equation modelling approach","volume":"60","author":"Santiago","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2023.01.002_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/1744666X.2019.1573673","article-title":"Measuring and managing appearance anxiety in patients with systemic sclerosis","volume":"15","author":"Gholizadeh","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.rdc.2023.01.002_bib7","doi-asserted-by":"crossref","first-page":"e018641","DOI":"10.1136\/bmjopen-2017-018641","article-title":"Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating \u2018not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN)","volume":"8","author":"Merz","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.rdc.2023.01.002_bib8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/art.22910","article-title":"Depression in patients with systemic sclerosis: a systematic review of the evidence","volume":"57","author":"Thombs","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.002_bib9","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","article-title":"Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey","volume":"50","author":"Bassel","year":"2011","journal-title":"Rheumatology"},{"issue":"Suppl 131","key":"10.1016\/j.rdc.2023.01.002_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.55563\/clinexprheumatol\/qo1ehz","article-title":"The Hospital Anxiety and Depression Scale in patients with systemic sclerosis: a psychometric and factor analysis in a monocentric cohort","volume":"39","author":"Garaiman","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.002_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/2397198319890813","article-title":"Validity and correlates of the Brief Satisfaction With Appearance Scale for patients with limited and diffuse systemic sclerosis: Analysis from the University of California, Los Angeles Scleroderma Quality of Life Study","volume":"5","author":"Fox","year":"2020","journal-title":"J\u00a0Scleroderma Relat Disord"},{"key":"10.1016\/j.rdc.2023.01.002_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000056240","article-title":"Psychiatric symptoms associated with scleroderma","volume":"70","author":"Angelopoulos","year":"2001","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.rdc.2023.01.002_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10067-019-04598-y","article-title":"Malnutrition, associated clinical factors, and depression in systemic sclerosis: a cross-sectional study","volume":"39","author":"T\u00fcrk","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.002_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pmn.2019.02.006","article-title":"Common Causes of Pain in Systemic Sclerosis: Frequency, Severity, and Relationship to Disease Status, Depression, and Quality of Life","volume":"20","author":"Ostojic","year":"2019","journal-title":"Pain Manag Nurs"},{"key":"10.1016\/j.rdc.2023.01.002_bib15","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1097\/RHU.0000000000001437","article-title":"Sleep Disturbance in Scleroderma","volume":"27","author":"Figueiredo","year":"2021","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.002_bib16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10067-012-1997-1","article-title":"Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools","volume":"31","author":"Strickland","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.002_bib17","doi-asserted-by":"crossref","first-page":"104421","DOI":"10.1016\/j.psyneuen.2019.104421","article-title":"Longitudinal analysis of loneliness and inflammation at older ages: English longitudinal study of ageing","volume":"110","author":"Vingeliene","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.rdc.2023.01.002_bib18","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10067-007-0567-4","article-title":"The impact of depression, microvasculopathy, and fibrosis on development of erectile dysfunction in men with systemic sclerosis","volume":"26","author":"Ostojic","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3899\/jrheum.140143","article-title":"Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis","volume":"42","author":"Hinchcliff","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/art.23329","article-title":"Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis","volume":"59","author":"Thombs","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib21","first-page":"641","article-title":"Multifactorial explanatory model of depression in patients with rheumatoid arthritis: a structural equation approach","volume":"37","author":"Santos","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.002_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/1756-185X.14041","article-title":"Assessment of loneliness in patients with inflammatory arthritis","volume":"24","author":"Emmungil","year":"2021","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2023.01.002_bib23","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/09638288.2019.1656292","article-title":"Reasons for not participating in scleroderma patient support groups: a comparison of results from the North American and European scleroderma support group surveys","volume":"43","author":"Kwakkenbos","year":"2021","journal-title":"Disabil Rehabil"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/2397198320930138","article-title":"Coping profiles and health outcomes among individuals with systemic sclerosis: A latent profile analysis approach","volume":"5","author":"Condon","year":"2020","journal-title":"J\u00a0Scleroderma Relat Disord"},{"issue":"10","key":"10.1016\/j.rdc.2023.01.002_bib25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3899\/jrheum.201612","article-title":"Effect of Coping Strategies on Patient and Physician Perceptions of Disease Severity and Disability in Systemic Sclerosis","volume":"48","author":"DiRenzo","year":"2021","journal-title":"J\u00a0Rheumatol"},{"issue":"6 Suppl 86","key":"10.1016\/j.rdc.2023.01.002_bib26","first-page":"206","article-title":"Work participation in patients with systemic sclerosis: a systematic review","volume":"32","author":"Decuman","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.002_bib27","doi-asserted-by":"crossref","first-page":"101667","DOI":"10.1016\/j.berh.2021.101667","article-title":"Employment outcomes in systemic sclerosis","volume":"35","author":"Lee","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.002_bib28","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/rheumatology\/ker523","article-title":"Work status and its determinants among patients with systemic sclerosis: a systematic review","volume":"51","author":"Schouffoer","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2023.01.002_bib29","first-page":"1","article-title":"Depression and loneliness may predict work inefficiency among professionally active adults","volume":"3","author":"\u0141","year":"2022","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.rdc.2023.01.002_bib30","doi-asserted-by":"crossref","first-page":"100392","DOI":"10.1016\/j.esxm.2021.100392","article-title":"Prevalence of Sexual Dysfunction in People With Systemic Sclerosis and the Associated Risk Factors: A Systematic Review","volume":"9","author":"Gao","year":"2021","journal-title":"Sex Med"},{"key":"10.1016\/j.rdc.2023.01.002_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/acr.20696","article-title":"Rates and correlates of sexual activity and impairment among women with systemic sclerosis","volume":"64","author":"Levis","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2023.01.002_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11926-016-0597-5","article-title":"Erectile Dysfunction in Systemic Sclerosis","volume":"18","author":"Jaeger","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rdc.2023.01.002_bib33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0002-9378(95)90576-6","article-title":"Genital tract abnormalities and female sexual function impairment in systemic sclerosis","volume":"172","author":"Bhadauria","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.rdc.2023.01.002_bib34","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3899\/jrheum.121540","article-title":"Sexual function in Italian women with systemic sclerosis is affected by disease-related and psychological concerns","volume":"40","author":"Bongi","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl 125","key":"10.1016\/j.rdc.2023.01.002_bib35","first-page":"59","article-title":"Sexual function in German women with systemic sclerosis compared with women with systemic lupus erythematosus and evaluation of a screening test","volume":"38","author":"Schmalzing","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.002_bib36","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.24728","article-title":"Impaired sexual function in women with systemic sclerosis: a cross-sectional study","volume":"61","author":"Schouffoer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.002_bib37","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/rheumatology\/ket305","article-title":"Clitoral blood flow in systemic sclerosis women: correlation with disease clinical variables and female sexual dysfunction","volume":"52","author":"Rosato","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2023.01.002_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/2397198318776593","article-title":"Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin","volume":"4","author":"Gigante","year":"2019","journal-title":"J\u00a0Scleroderma Relat Disord"},{"key":"10.1016\/j.rdc.2023.01.002_bib39","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.autrev.2015.07.016","article-title":"The clinical relevance of sexual dysfunction in systemic sclerosis","volume":"14","author":"Bruni","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2023.01.002_bib40","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.12968\/bjon.2005.14.19.19944","article-title":"Restoring pelvic floor function in men: review of RCTs","volume":"14","author":"Dorey","year":"2005","journal-title":"Br J Nurs"},{"key":"10.1016\/j.rdc.2023.01.002_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J\u00a0Sex Marital Ther"},{"key":"10.1016\/j.rdc.2023.01.002_bib42","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/ijerph19010612","article-title":"Female Sexual Dysfunction and Pelvic Floor Muscle Function Associated with Systemic Sclerosis: A Cross-Sectional Study","volume":"19","author":"He\u0159m\u00e1nkov\u00e1","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.rdc.2023.01.002_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","article-title":"Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)","volume":"193","author":"Barber","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"4Pt1","key":"10.1016\/j.rdc.2023.01.002_bib44","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.lpm.2015.08.009","article-title":"Systemic sclerosis: Sexual dysfunction and lower urinary tract symptoms in 73 patients","volume":"45","author":"Sanchez","year":"2016","journal-title":"Presse Med"},{"key":"10.1016\/j.rdc.2023.01.002_bib45","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/ar3748","article-title":"Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group","volume":"14","author":"Foocharoen","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 131","key":"10.1016\/j.rdc.2023.01.002_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.55563\/clinexprheumatol\/e9n3n9","article-title":"Erectile function and connective tissue diseases. Prevalence of erectile dysfunction in German men with systemic sclerosis compared with other connective tissue diseases and healthy subjects","volume":"39","author":"Krittian","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.002_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.rdc.2023.01.002_bib48","first-page":"1712","article-title":"Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels","volume":"34","author":"Proietti","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib49","first-page":"560","article-title":"Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database. Rheumatology (Oxford)","volume":"52","author":"Schneeberger","year":"2013","journal-title":"Mar"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.002_bib50","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/acr.23729","article-title":"Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity","volume":"71","author":"Pauling","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib51","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10067-021-05598-7","article-title":"How do patients define Raynaud's phenomenon? Differences between primary and secondary disease","volume":"40","author":"Murphy","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/art.30071","article-title":"Cigarette smoking in patients with systemic sclerosis","volume":"63","author":"Hudson","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2023.01.002_bib53","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/rheumatology\/kev201","article-title":"Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.rdc.2023.01.002_bib54","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3899\/jrheum.180818","article-title":"Factors Influencing Raynaud Condition Score Diary Outcomes in Systemic Sclerosis","volume":"46","author":"Pauling","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.002_bib55","first-page":"1734","article-title":"Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis","volume":"26","author":"Watson","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/rheumatology\/key026","article-title":"The patient experience of Raynaud's phenomenon in systemic sclerosis","volume":"58","author":"Pauling","year":"2019","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.rdc.2023.01.002_bib57","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/acr.23475","article-title":"Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis","volume":"70","author":"Pauling","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.002_bib58","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.semarthrit.2018.08.001","article-title":"Exploring the patient experience of digital ulcers in systemic sclerosis","volume":"48","author":"Hughes","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13075-019-2080-y","article-title":"Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden","volume":"21","author":"Morrisroe","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib60","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2133.2008.09004.x","article-title":"Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors","volume":"160","author":"Sunderkotter","year":"2009","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.002_bib61","first-page":"2423","article-title":"Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study","volume":"34","author":"Hachulla","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2023.01.002_bib62","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/annrheumdis-2015-208121","article-title":"Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry","volume":"75","author":"Matucci-Cerinic","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.002_bib63","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/acr.24127","article-title":"Multicenter Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic Sclerosis","volume":"72","author":"Hughes","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.002_bib64","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/rheumatology\/keaa037","article-title":"Patient experiences of digital ulcer development and evolution in systemic sclerosis","volume":"59","author":"Hughes","year":"2020","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.002_bib65","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acr.20673","article-title":"Scleroderma digital ulcers complicated by infection with fecal pathogens","volume":"64","author":"Giuggioli","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.rdc.2023.01.002_bib66","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/rheumatology\/kew224","article-title":"BSR and BHPR guideline for the treatment of systemic sclerosis","volume":"55","author":"Denton","year":"2016","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.002_bib67","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/rheumatology\/kew313","article-title":"Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study","volume":"55","author":"Baron","year":"2016","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib68","first-page":"158","article-title":"Systemic Sclerosis Related Calcinosis: Patients Provide What Specialists Want to Learn","volume":"167","author":"Christensen","year":"2015","journal-title":"J\u00a0La State Med Soc"},{"issue":"11","key":"10.1016\/j.rdc.2023.01.002_bib69","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.40557","article-title":"Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study","volume":"70","author":"Jaeger","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.002_bib70","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1002\/art.10685","article-title":"Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis","volume":"46","author":"Harrison","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.01.002_bib71","article-title":"Patient Experience of Systemic Sclerosis related Calcinosis: An International Study Informing Clinical Trials, Practice and the Development of the Mawdsley Calcinosis Questionnaire","author":"Saketkoo","year":"2022","journal-title":"Rheum Dis Clin"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.002_bib72","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib73","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3138\/ptc.2012-40","article-title":"Evidence-based management of hand and mouth disability in a woman living with diffuse systemic sclerosis (scleroderma)","volume":"65","author":"Poole","year":"2013","journal-title":"Physiother Can. Fall"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib74","doi-asserted-by":"crossref","first-page":"e33281","DOI":"10.1371\/journal.pone.0033281","article-title":"Canadian Scleroderma Research G. Sociodemographic and disease correlates of body image distress among patients with systemic sclerosis","volume":"7","author":"Jewett","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.002_bib75","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/1744666X.2018.1464390","article-title":"The challenge of establishing treatment efficacy for cutaneous vascular manifestations of systemic sclerosis","volume":"14","author":"Pauling","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.rdc.2023.01.002_bib76","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/annrheumdis-2014-205295","article-title":"Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study","volume":"75","author":"Avouac","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2023.01.002_bib77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.semarthrit.2019.11.003","article-title":"Musculoskeletal hand involvement in systemic sclerosis","volume":"50","author":"Sandler","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib78","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3899\/jrheum.191374","article-title":"Functional index-3: a valid and reliable functional outcome assessment measure in patients with dermatomyositis and polymyositis","volume":"48","author":"Ernste","year":"2021","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.002_bib79","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/2397198319886496","article-title":"Patient-reported outcome instruments in clinical trials of systemic sclerosis","volume":"5","author":"Pauling","year":"2020","journal-title":"Journal of Scleroderma and Related Disorders"},{"issue":"suppl_5","key":"10.1016\/j.rdc.2023.01.002_bib80","doi-asserted-by":"crossref","first-page":"v23","DOI":"10.1093\/rheumatology\/kex194","article-title":"Points to consider for designing trials in systemic sclerosis patients with arthritic involvement","volume":"56","author":"Clements","year":"2017","journal-title":"Rheumatology"},{"issue":"Suppl 131","key":"10.1016\/j.rdc.2023.01.002_bib81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.55563\/clinexprheumatol\/cl3bbb","article-title":"Sensitivity to change of joint count composite indices in 72 patients with systemic sclerosis","volume":"39","author":"L\u00f3r\u00e1nd","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.01.002_bib82","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/rheumatology\/kep250","article-title":"Ultrasonographic features of the hand and wrist in systemic sclerosis","volume":"48","author":"Cuomo","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2023.01.002_bib83","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/s00330-006-0420-1","article-title":"Imaging features of musculoskeletal involvement in systemic sclerosis","volume":"17","author":"Boutry","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1016\/j.rdc.2023.01.002_bib84","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5301\/jsrd.5000228","article-title":"Musculoskeletal Involvement in Systemic Sclerosis: An Unexplored Aspect of the Disease","volume":"2","author":"Varj\u00fa","year":"2017","journal-title":"Journal of Scleroderma and Related disorders"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.002_bib85","doi-asserted-by":"crossref","first-page":"141e8","DOI":"10.1080\/03009742.2018.1477990","article-title":"Muscle endurance, strength, and active range of motion in patients with different subphenotypes in systemic sclerosis: a cross-sectional cohort study","volume":"48","author":"Pettersson","year":"2019","journal-title":"Scand J Rheumatol"},{"issue":"23","key":"10.1016\/j.rdc.2023.01.002_bib86","first-page":"2865e71","article-title":"Cardiac complications in systemic sclerosis: early diagnosis and treatment","volume":"132","author":"Nie","year":"2019","journal-title":"Chin Med J (Engl)."},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib87","doi-asserted-by":"crossref","first-page":"647e54","DOI":"10.1093\/rheumatology\/keu350","article-title":"Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography","volume":"54","author":"Rodr\u00edguez-Reyna","year":"2015","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.002_bib88","doi-asserted-by":"crossref","first-page":"273e8","DOI":"10.1016\/j.semarthrit.2019.02.005","article-title":"Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients","volume":"49","author":"Rodr\u00edguez-Reyna","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib89","doi-asserted-by":"crossref","first-page":"194e203","DOI":"10.1016\/0002-8703(93)90075-K","article-title":"Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association","volume":"125","author":"Follansbee","year":"1993","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.rdc.2023.01.002_bib90","doi-asserted-by":"crossref","first-page":"1474e7","DOI":"10.1136\/ard.2008.095919","article-title":"A\u00a0descriptive and prognostic study of systemic sclerosis-associated myopathies","volume":"68","author":"Ranque","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.002_bib91","doi-asserted-by":"crossref","first-page":"498e505","DOI":"10.3109\/03009741003774626","article-title":"Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features","volume":"39","author":"Ranque","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.002_bib92","doi-asserted-by":"crossref","first-page":"662e8","DOI":"10.1002\/art.1780240506","article-title":"Association of myositis and myocarditis in progressive systemic sclerosis","volume":"24","author":"West","year":"1981","journal-title":"Arthritis Rheum"},{"issue":"Suppl 131","key":"10.1016\/j.rdc.2023.01.002_bib93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.55563\/clinexprheumatol\/tt4ilu","article-title":"Diagnostic measures for patients with systemic sclerosis-associated myopathy","volume":"39","author":"Baumberger","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib94","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/agm2.12198","article-title":"Promoting early management of frailty in the new normal: An updated software tool in addressing the need of virtual assessment of frailty at points of care","volume":"5","author":"Sepehri","year":"2022","journal-title":"Aging Med (Milton)"},{"key":"10.1016\/j.rdc.2023.01.002_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2017.05.012","article-title":"Severity and features of frailty in systemic sclerosis-associated interstitial lung disease","volume":"129","author":"Guler","year":"2017","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.rdc.2023.01.002_bib96","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/resp.14066","article-title":"Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study","volume":"26","author":"Farooqi","year":"2021","journal-title":"Respirology"},{"key":"10.1016\/j.rdc.2023.01.002_bib97","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.3390\/ijms23073501","article-title":"Myokines and Resistance Training: A Narrative Review","volume":"23","author":"Zunner","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.rdc.2023.01.002_bib98","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2023.01.002_bib99","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib100","doi-asserted-by":"crossref","first-page":"441e50","DOI":"10.1093\/rheumatology\/kex182","article-title":"Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group","volume":"57","author":"Jaeger","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib101","doi-asserted-by":"crossref","first-page":"410e3","DOI":"10.1093\/rheumatology\/kex420","article-title":"Wild\ufb02owers abundant in the garden of systemic sclerosis research, while hopeful exotics will one day bloom","volume":"57","author":"Saketkoo","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.002_bib102","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrgastro.2016.99","article-title":"Current management of the gastrointestinal complications of systemic sclerosis","volume":"13","author":"Emmanuel","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.rdc.2023.01.002_bib103","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/acr.23479","article-title":"Determining the risk factors and clinical features associated with severe gastrointestinal dysmotility in systemic sclerosis","volume":"70","author":"McMahan","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib104","doi-asserted-by":"crossref","first-page":"459e73","DOI":"10.1016\/j.rdc.2015.04.007","article-title":"Systemic sclerosis: gastrointestinal disease and its management","volume":"41","author":"Gyger","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"issue":"6 Suppl 86","key":"10.1016\/j.rdc.2023.01.002_bib105","first-page":"214e21","article-title":"Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis","volume":"32","author":"Hansi","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.002_bib106","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s00296-011-1988-6","article-title":"Profile of gastrointestinal involvement in patients with systemic sclerosis","volume":"32","author":"Schmeiser","year":"2012","journal-title":"Rheumatol Int"},{"issue":"9","key":"10.1016\/j.rdc.2023.01.002_bib107","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.24730","article-title":"Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument","volume":"61","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.002_bib108","doi-asserted-by":"crossref","first-page":"163e74","DOI":"10.2174\/1573398X11666150619183527","article-title":"Outcome measures for clinical trials in interstitial lung diseases","volume":"11","author":"Lammi","year":"2015","journal-title":"Curr Respir Med Rev"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.002_bib109","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/thoraxjnl-2013-204202","article-title":"Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials","volume":"69","author":"Saketkoo","year":"2014","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3899\/jrheum.131251","article-title":"Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases","volume":"41","author":"Saketkoo","year":"2014","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.002_bib111","doi-asserted-by":"crossref","first-page":"175e83","DOI":"10.2174\/1573398X11666150619182624","article-title":"Patient perspectives in OMERACT provide an anchor for future metric development and improved approaches to healthcare delivery in connective tissue disease related interstitial lung disease (CTD-ILD)","volume":"11","author":"Mittoo","year":"2015","journal-title":"Curr Respir Med Rev"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib112","doi-asserted-by":"crossref","first-page":"614e21","DOI":"10.1378\/chest.11-0801","article-title":"Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: \ufb01ndings from the Scleroderma Lung Study","volume":"142","author":"Theodore","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib113","doi-asserted-by":"crossref","first-page":"813e20","DOI":"10.1016\/j.chest.2016.11.052","article-title":"Improved cough and cough-speci\ufb01c quality of life in patients treated for scleroderma-related interstitial lung disease: results of scleroderma lung study II","volume":"151","author":"Tashkin","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2023.01.002_bib114","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/MAJ.0b013e3182a55d24","article-title":"The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope","volume":"347","author":"Saketkoo","year":"2014","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rdc.2023.01.002_bib115","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1440-1843.2012.02133.x","article-title":"The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease","volume":"17","author":"Wilsher","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.rdc.2023.01.002_bib116","doi-asserted-by":"crossref","DOI":"10.1097\/MCP.0000000000000880","article-title":"Ageing with Interstitial Lung Disease: Preserving Health and Well Being","author":"Saketkoo","year":"2022","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.002_bib117","first-page":"139e45","article-title":"Geographic disparity in systemic sclerosis mortality in the United States: 1999e2017","volume":"6","author":"Rodriguez-Pla","year":"2021","journal-title":"J\u00a0Scleroderma Relat Disord"},{"issue":"9","key":"10.1016\/j.rdc.2023.01.002_bib118","doi-asserted-by":"crossref","first-page":"708e19","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"25","key":"10.1016\/j.rdc.2023.01.002_bib119","doi-asserted-by":"crossref","first-page":"2655e66","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2023.01.002_bib120","first-page":"230","article-title":"Wrist-Sensor Pulse Oximeter Enables Prolonged Patient Monitoring in Chronic Lung Diseases","volume":"43","author":"Guber","year":"2019","journal-title":"J\u00a0Med Syst"},{"issue":"11","key":"10.1016\/j.rdc.2023.01.002_bib121","first-page":"1892e6","article-title":"Performance characteristics of pulmonary function tests for the detection of interstitial lung disease in adults with early diffuse cutaneous systemic sclerosis","volume":"72","author":"Bernstein","year":"2020","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"2 Suppl","key":"10.1016\/j.rdc.2023.01.002_bib122","first-page":"31e40","article-title":"Natural history of systemic sclerosis-related interstitial lung disease: how to identify a progressive \ufb01brosing phenotype","volume":"5","author":"Volkmann","year":"2020","journal-title":"J\u00a0Scleroderma Relat Disord"},{"issue":"7","key":"10.1016\/j.rdc.2023.01.002_bib123","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2023.01.002_bib124","doi-asserted-by":"crossref","first-page":"765e70","DOI":"10.1002\/art.1780350709","article-title":"Isolated diffusing capacity reduction in systemic sclerosis","volume":"35","author":"Steen","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib125","doi-asserted-by":"crossref","first-page":"489e95","DOI":"10.1002\/acr.22121","article-title":"Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in sclero- derma registry","volume":"66","author":"Chung","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib126","doi-asserted-by":"crossref","first-page":"647e54","DOI":"10.1093\/rheumatology\/keu350","article-title":"Assessment of myocardial \ufb01brosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography","volume":"54","author":"Rodr\u00edguez-Reyna","year":"2015","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.002_bib127","doi-asserted-by":"crossref","first-page":"273e8","DOI":"10.1016\/j.semarthrit.2019.02.005","article-title":"Myocardial \ufb01brosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients","volume":"49","author":"Rodr\u00edguez-Reyna","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib128","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/2397198318786158","article-title":"Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: Why and how to screen","volume":"3","author":"Lazzaroni","year":"2018","journal-title":"J\u00a0Scleroderma Relat Disord"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13075-021-02548-1","article-title":"Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort","volume":"23","author":"Jaafar","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.002_bib130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13075-020-2141-2","article-title":"ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis","volume":"22","author":"Butikofer","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.002_bib132","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","article-title":"International Scleroderma Renal Crisis Study I. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey","volume":"43","author":"Hudson","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.002_bib133","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/BOR.0b013e3283108df7","article-title":"Diagnosis, management and prevention of scleroderma renal disease","volume":"20","author":"Penn","year":"2008","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2023.01.002_bib134","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.002_bib135","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1186\/ar3544","article-title":"Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort","volume":"13","author":"Nikpour","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 2","key":"10.1016\/j.rdc.2023.01.002_bib136","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/annrheumdis-2015-eular.3605","article-title":"AB0712 Development of a \u201cRenal Crisis Prevention Card\u201d as an Education Tool to Improve Outcomes in High Risk Patients with Systemic Sclerosis (SSC)","volume":"74","author":"Shapiro","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 100","key":"10.1016\/j.rdc.2023.01.002_bib137","first-page":"106","article-title":"UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis","volume":"34","author":"Lynch","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib138","first-page":"164","article-title":"Vaccination coverage in children with rheumatic diseases","volume":"38","author":"Bizjak","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib139","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jbspin.2016.03.013","article-title":"Pneumococcal and influenza vaccination rates in patients treated with corticosteroids and\/or immunosuppressive therapies for systemic autoimmune diseases: A cross-sectional study","volume":"84","author":"Assala","year":"2017","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib140","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/rheumatology\/kep440","article-title":"Low influenza vaccination rate among patients with systemic sclerosis","volume":"49","author":"Mouthon","year":"2010","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.002_bib141","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/jech-2011-200168","article-title":"Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses","volume":"66","author":"Wotton","year":"2012","journal-title":"J\u00a0Epidemiol Community Health"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.002_bib142","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1525-1470.2006.00289.x","article-title":"Deep morphea after vaccination in two young children","volume":"23","author":"Torrelo","year":"2006","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib143","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1525-1470.2011.01548.x","article-title":"Postvaccination morphea profunda in a child","volume":"29","author":"Khaled","year":"2012","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib144","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/rheumatology\/ker389","article-title":"Protective effect of A\/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study","volume":"51","author":"Adler","year":"2012","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ndt\/13.1.160","article-title":"Suppression of the humoral immune response by mycophenolate mofetil","volume":"13","author":"Smith","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1016\/j.rdc.2023.01.002_bib146","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/art.40937","article-title":"Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases","volume":"71","author":"Md Yusof MY","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.002_bib147","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10875-007-9120-0","article-title":"Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines","volume":"27","author":"Brinkman","year":"2007","journal-title":"J\u00a0Clin Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2023.01.002_bib148","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rdc.2023.01.002_bib149","author":"CfDCa"},{"issue":"5","key":"10.1016\/j.rdc.2023.01.002_bib150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"6 Suppl 86","key":"10.1016\/j.rdc.2023.01.002_bib152","first-page":"145","article-title":"Screening of human papillomavirus infection in women with systemic sclerosis","volume":"32","author":"Martin","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.002_bib153","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.1780281204","article-title":"Cancer and systemic sclerosis. An epidemiologic study","volume":"28","author":"Roumm","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.002_bib154","first-page":"1113","article-title":"A\u00a0cohort study of cancer incidence in systemic sclerosis","volume":"33","author":"Derk","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.002_bib155","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.rdc.2023.01.002_bib156","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.rdc.2023.01.002_bib157","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/acr.24076","article-title":"Incidence, Risk Factors, and Outcomes of Cancer in Systemic Sclerosis","volume":"72","author":"Morrisroe","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.002_bib158","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/art.40065","article-title":"Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated Scleroderma","volume":"69","author":"Shah","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib159","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/art.39022","article-title":"Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma","volume":"67","author":"Shah","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.01.002_bib160","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/BOR.0b013e32834a5081","article-title":"Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications","volume":"23","author":"Shah","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2023.01.002_bib161","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1136\/annrheumdis-2011-201176","article-title":"Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis","volume":"71","author":"Ngian","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2023.01.002_bib162","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/art.30380","article-title":"Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis","volume":"63","author":"Au","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib163","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/art.23540","article-title":"A\u00a0pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls","volume":"59","author":"Khurma","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2023.01.002_bib164","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/annrheumdis-2012-202007","article-title":"The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study","volume":"72","author":"Man","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.rdc.2023.01.002_bib165","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3899\/jrheum.130032","article-title":"Low bone density in systemic sclerosis. A systematic review","volume":"40","author":"Omair","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.002_bib166","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1756-185X.14254","article-title":"Screening rates and prevalence of osteoporosis in a real-world, Australian systemic sclerosis cohort","volume":"25","author":"Bimal","year":"2022","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2023.01.002_bib167","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1503\/cmaj.071330","article-title":"Use of proton pump inhibitors and risk of osteoporosis-related fractures","volume":"179","author":"Targownik","year":"2008","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"2","key":"10.1016\/j.rdc.2023.01.002_bib168","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/03009742.2021.1917142","article-title":"Validity and reliability of the Swedish version of the Self-Efficacy for Managing Chronic Disease scale for individuals with systemic sclerosis","volume":"51","author":"Mattsson","year":"2022","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2023.01.002_bib169","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00296-013-2680-9","article-title":"Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life","volume":"33","author":"Sariyildiz","year":"2013","journal-title":"Rheumatol Int"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:30:51Z","timestamp":1760182251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X23000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":169,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0889857X23000029"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2023.01.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2023.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}